Figure 8 — The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma

Research Paper|Volume 15, Issue 21|pp. 11918–11939

The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma

Back to articleFigure 8(8 of 10)

100%

Figure 8.Correlation analysis of risk score and drug sensitivity. IC 50 of (A) Paclitaxel, (B) Sorafenib, (C) AKT inhibitor VIII, (D) Rapamycin, (E) Pazopanib, (F) Lapatinib, (G) Crizotinib, and (H) Sunitinib. (I–P) Correlation analysis of risk score and frug sensitivity.